Fentanyl

NDEWS Publications

New Hampshire HotSpot
The New Hampshire HotSpot study was conducted in 2016 in response to a sharp increase in illicit fentanyl-related overdose deaths.

 

NDEWS Special Report


NDEWS Sentinel Community Site Advance Report 2016

Fact Sheets/Alerts

DEA Intelligence Brief: Fentanyl Remains the Most Significant Synthetic Opioid Threat and Poses the Greatest Threat to the Opioid User Market in the United States (MAY 2018)

EMCDDA / Europol - New Psychoactive Substances:

NDEWS News / DEA: Fentanyl Accounted for the Majority of Opioid Identifications in DEA Drug Evidence Analyzed in the Third Quarter of 2017

DEA / NFLIS Brief:

MMWR:

ONDCP: Acrylfentanyl and Naloxone Effectiveness (July 2017)

DEA: NFLIS BRIEF: Fentanyl 2001-2015

Georgia Bureau of Investigation: Crime Lab Identifies Central Georgia Counterfeit Pills

NYC Health Department Warns New Yorkers about Cocaine Laced with Fentanyl

Wright State University: Research Update on Fentanyl Outbreaks in Dayton, Ohio (April 2017)

CDC Health Alert Network (2016): Influx of Fentanyl-laced Counterfeit Pills and Toxic Fentanyl-related Compounds Further Increases Risk of Fentanyl-related Overdose and Fatalities

CDC Advisory 2015: Increases in Fentanyl Drug Confiscations and Fentanyl-related Overdose Fatalities

CDC Alert 2013: Recommendations for Laboratory Testing for Acetyl Fentanyl and Patient Evaluation and Treatment for Overdose with Synthetic Opioid

Hamilton County, Ohio: